A prospective study of agents associated with acute respiratory infection among young american indian children

Pediatric Infectious Disease Journal

Volumn 32, Issue 8, 2013, Pages

  Bhat, Niranjan ^a   Tokarz, Rafal ^b   Jain, Komal ^b   Haq, Saddef ^b   Weatherholtz, Robert ^a   Chandran, Aruna ^a   Karron, Ruth ^a   Reid, Raymond ^a   Santosham, Mathuram ^a   O'Brien, Katherine L ^a   Lipkin, W Ian ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Medicine   (United States)

Author keywords

American Indian; child; diagnosis; influenza; respiratory infections

Indexed keywords

MOTAVIZUMAB; PLACEBO;

2009 H1N1 INFLUENZA; AMERICAN INDIAN; ARTICLE; BACTERIUM EXAMINATION; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN RHINOVIRUS; INFECTION RISK; INFECTIOUS PNEUMONIA; INFLUENZA VIRUS; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; VIRUS EXAMINATION;

BACTERIA; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INFANT; MALE; NASAL LAVAGE FLUID; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SOUTHWESTERN UNITED STATES; VIRUS DISEASES; VIRUSES;

EID: 84880646369     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828ff4bc     Document Type: Article

References (53)

1. Holman RC, Curns AT, Cheek JE, et al. Infectious disease hospitalizations among American Indian and Alaska native infants. Pediatrics. 2003;111:E176-E182.
2. Peck AJ, Holman RC, Curns AT, et al. Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J. 2005;24:342-351.
3. O'Brien KL, Shaw J, Weatherholtz R, et al. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. Am J Epidemiol. 2004;160:270-278.
4. Bockova J, O'Brien KL, Oski J, et al. Respiratory syncytial virus infection in Navajo and White Mountain Apache children. Pediatrics. 2002;110(2 Pt 1):e20.
5. Millar EV, O'Brien KL, Levine OS, et al. Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. Am J Public Health. 2000;90:1550-1554.
6. Weatherholtz R, Millar EV, Moulton LH, et al. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis. 2010;50: 1238-1246.
7. Davidson M, Parkinson AJ, Bulkow LR, et al. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990-ethnic differences and opportunities for prevention. J Infect Dis. 1994;170:368-376.
8. Singleton R, Hammitt L, Hennessy T, et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics. 2006;118:e421-e429.
9. Singleton RJ, Bruden D, Bulkow LR. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta. Pediatr Infect Dis J. 2007;26(suppl 11):S46-S50.
10. Singleton RJ, Butler JC, Bulkow LR, et al. Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults. Vaccine. 2007;25:2288-2295.
11. Centers for Disease Control and Prevention. Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives-12 states, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1341-1344.
12. LaRuche G, Tarantola A, Barboza P, et al.; epidemic intelligence team at InVS. The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill. 2009;14:19366.
13. Groom AV, Jim C, Laroque M, et al. Pandemic influenza preparedness and vulnerable populations in tribal communities. Am J Public Health. 2009;99(suppl 2):S271-S278.
14. Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and metaanalysis. Lancet. 2011;378:1917-1930.
15. Dee DL, Bensyl DM, Gindler J, et al. Racial and ethnic disparities in hospitalizations and deaths associated with 2009 pandemic Influenza A (H1N1) virus infections in the United States. Ann Epidemiol. 2011;21:623-630.
16. Chandran A, Millar E, Weatherholtz R, et al. Safety and efficacy of motavizumab in the prevention of RSV disease in healthy infants. Pediatr Academic Societies Annual Meeting Abstracts. 2008:4460-4465.
17. Briese T, Palacios G, Kokoris M, et al. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerging Infect Dis. 2005;11: 310-313.
18. Lamson D, Renwick N, Kapoor V, et al. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis. 2006;194:1398-1402.
19. Dominguez SR, Briese T, Palacios G, et al. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol. 2008;43:219-222.
20. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE. 2009;4:e8540.
21. Tokarz R, Kapoor V, Wu W, et al. Longitudinal molecular microbial analysis of influenza-like illness in New York City, May 2009 through May 2010. Virol J. 2011;8:288.
22. Williams JV, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-450.
23. Schildgen V, van den Hoogen B, Fouchier R, et al. Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev. 2011;24:734-754.
24. Edwards KM, Zhu Y, Griffin MR, et al.; New Vaccine Surveillance Network. Burden of human metapneumovirus infection in young children. N Engl J Med. 2013;368:633-643.
25. Singleton RJ, Holman RC, Folkema AM, et al. Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr. 2012;161:296-302.e2.
26. Kronman MP, Hersh AL, Feng R, et al. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007. Pediatrics. 2011;127:411-418.
27. Centers for Disease Control and Prevention. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine-United States, 1997-2006. MMWR Morb Mortal Wkly Rep 2009;58:1-4.
28. Groom AV, Santibanez TA, Bryan RT. Vaccination coverage among American Indian and Alaska native children, 2006-2010. Pediatrics. 2012;130:e1592-e1599.
29. Dawood FS, Fiore A, Kamimoto L, et al.; Emerging Infections Program Network. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr. 2010;157:808-814.
30. Poehling KA, Edwards KM, Griffin MR, et al. The burden of influenza in young children, 2004-2009. Pediatrics. 2013;131:207-216.
31. Louie JK, Acosta M, Winter K, et al.; California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302: 1896-1902
32. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic, Bautista E, Chotpitayasunondh T, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708-1719.
33. Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12:687-695.
34. Hennessy TW, Singleton RJ, Bulkow LR, et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine. 2005;23:5464-5473.
35. Millar EV, O'Brien KL, Watt JP, et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis. 2006;43:8-15.
36. O'Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis. 2007;196:1211-1220.
37. Millar EV, O'Brien KL, Zell ER, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2009;28:711-716.
38. Millar EV, Pimenta FC, Roundtree A, et al. Pre-and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities. Clin Infect Dis. 2010;51:1258-1265.
39. Scott JR, Hinds J, Gould KA, et al. Nontypeable pneumococcal isolates among navajo and white mountain apache communities: are these really a cause of invasive disease? J Infect Dis. 2012;206:73-80.
40. Wroe PC, Lee GM, Finkelstein JA, et al. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012;31:249-254.
41. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811-813.
42. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571-582.
43. Templeton KE, Scheltinga SA, van den Eeden WC, et al. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345-351.
44. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63:42-48.
45. Peltola V, Heikkinen T, Ruuskanen O, et al. Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J. 2011;30:456-461.
46. Launes C, de-Sevilla MF, Selva L, et al. Viral coinfection in children less than five years old with invasive pneumococcal disease. Pediatr Infect Dis J. 2012;31:650-653.
47. Vu HT, Yoshida LM, Suzuki M, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;30:11-18.
48. Albrich WC, Madhi SA, Adrian PV, et al. Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis. 2012;54:601-609.
49. Drews AL, Atmar RL, Glezen WP, et al. Dual respiratory virus infections. Clin Infect Dis. 1997;25:1421-1429.
50. Cilla G, Oñate E, Perez-Yarza EG, et al. Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J Med Virol. 2008;80:1843-1849.
51. Canducci F, Debiaggi M, Sampaolo M, et al. Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol. 2008;80:716-723.
52. Singleton RJ, Bulkow LR, Miernyk K, et al. Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol. 2010;82:1282-1290.
53. Martin ET, Kuypers J, Wald A, et al. Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Influenza Other Respi Viruses. 2012;6:71-77.